Literature DB >> 11507224

Interaction with the Epstein-Barr virus helicase targets Zta to DNA replication compartments.

G Liao1, F Y Wu, S D Hayward.   

Abstract

Zta has a dual role in the Epstein-Barr virus (EBV) lytic cycle, acting as a key regulator of EBV lytic gene expression and also being essential for lytic viral DNA replication. Zta's replication function is mediated in part through interactions with the core viral replication proteins. We now show interaction between Zta and the helicase (BBLF4) and map the binding region to within amino acids (aa) 22 to 86 of the Zta activation domain. In immunofluorescence assays, green fluorescent protein (GFP)-tagged BBLF4 localized to the cytoplasm of transfected cells. Cotransfection of Zta resulted in translocation of BBLF4-GFP into the nucleus indicating interaction between these two proteins. However, Zta with a deletion of aa 24 to 86 was unable to mediate nuclear translocation of BBLF4-GFP. Results obtained with Zta variants carrying deletions across the aa 24 to 86 region indicated more than one contact site for BBLF4 within this domain, and this was reinforced by the behavior of the four-point mutant Zta (m22/26,74/75), which was severely impaired for BBLF4 interaction. Binding of BBLF4 to Zta was confirmed using GST affinity assays. In both cotransfection-replication assays and replication assays performed in EBV-positive P3HR1 cells, the Zta (m22/26,74/75) mutant was replication defective. In Zta-transfected D98-HR1 cells, replication compartments could be detected by immunofluorescence staining using anti-BMRF1 monoclonal antibody. Cells transfected with Zta variants that were defective for helicase binding still formed replication compartments, but Zta was excluded from these compartments. These experiments reveal a role for the Zta-helicase interaction in targeting Zta to sites of viral DNA replication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507224      PMCID: PMC115124          DOI: 10.1128/jvi.75.18.8792-8802.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.

Authors:  N Taylor; E Flemington; J L Kolman; R P Baumann; S H Speck; G Miller
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Formation of intranuclear replication compartments of Epstein-Barr virus with redistribution of BZLF1 and BMRF1 gene products.

Authors:  S Takagi; K Takada; T Sairenji
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

3.  Cooperation of EBV DNA polymerase and EA-D(BMRF1) in vitro and colocalization in nuclei of infected cells.

Authors:  A Kiehl; D I Dorsky
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

4.  Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues.

Authors:  E Flemington; S H Speck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Identification of transactivator and nuclear localization domains in the Epstein-Barr virus DNA polymerase accessory protein, BMRF1.

Authors:  Q Zhang; E Holley-Guthrie; D Dorsky; S Kenney
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

6.  The ZEBRA activation domain: modular organization and mechanism of action.

Authors:  T Chi; M Carey
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

7.  cis-acting elements in the lytic origin of DNA replication of Epstein-Barr virus.

Authors:  A Schepers; D Pich; J Mankertz; W Hammerschmidt
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation.

Authors:  J L Kolman; N Taylor; D R Marshak; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  The lytic origin of herpesvirus papio is highly homologous to Epstein-Barr virus ori-Lyt: evolutionary conservation of transcriptional activation and replication signals.

Authors:  J J Ryon; E D Fixman; C Houchens; J Zong; P M Lieberman; Y N Chang; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase.

Authors:  J Burkham; D M Coen; S K Weller
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  29 in total

1.  Evidence for DNA hairpin recognition by Zta at the Epstein-Barr virus origin of lytic replication.

Authors:  Andrew J Rennekamp; Pu Wang; Paul M Lieberman
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

2.  Initiation of Epstein-Barr virus lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt.

Authors:  Andrew J Rennekamp; Paul M Lieberman
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

3.  Multivalent sequence recognition by Epstein-Barr virus Zta requires cysteine 171 and an extension of the canonical B-ZIP domain.

Authors:  Pu Wang; Latasha Day; Paul M Lieberman
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

4.  The Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressor.

Authors:  Gangling Liao; Jian Huang; Elizabeth D Fixman; S Diane Hayward
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Phosphoacceptor site S173 in the regulatory domain of Epstein-Barr Virus ZEBRA protein is required for lytic DNA replication but not for activation of viral early genes.

Authors:  Ayman El-Guindy; Lee Heston; Henri-Jacques Delecluse; George Miller
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

6.  Interaction of Kaposi's sarcoma-associated herpesvirus ORF59 with oriLyt is dependent on binding with K-Rta.

Authors:  Cyprian C Rossetto; Ni Ketut Susilarini; Gregory S Pari
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

7.  Topoisomerase I and RecQL1 function in Epstein-Barr virus lytic reactivation.

Authors:  Pu Wang; Andrew J Rennekamp; Yan Yuan; Paul M Lieberman
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

8.  Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.

Authors:  Stacy R Hagemeier; Sarah J Dickerson; Qiao Meng; Xianming Yu; Janet E Mertz; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

9.  CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.

Authors:  Frederick Y Wu; Shizhen Emily Wang; Honglin Chen; Ling Wang; S Diane Hayward; Gary S Hayward
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1).

Authors:  Frederick Y Wu; Shizhen Emily Wang; Qi-Qun Tang; Masahiro Fujimuro; Chuang-Jiun Chiou; Qizhi Zheng; Honglin Chen; S Diane Hayward; M Daniel Lane; Gary S Hayward
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.